Pregabalin and Dermatitis atopic aggravated - a phase IV clinical study of FDA data

Summary:

Dermatitis atopic aggravated is reported as a side effect among people who take Pregabalin (pregabalin), especially for people who are female, 50-59 old, also take Dupixent, and have Eczema.

The phase IV clinical study analyzes which people have Dermatitis atopic aggravated when taking Pregabalin. It is created by eHealthMe based on reports of 73,056 people who have side effects when taking Pregabalin from the FDA, and is updated regularly.

What is Pregabalin?

Pregabalin has active ingredients of pregabalin. It is often used in fibromyalgia. eHealthMe is studying from 74,069 Pregabalin users. Check the latest studies of Pregabalin.

What is Dermatitis atopic aggravated?

Dermatitis atopic aggravated (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder) is found to be associated with 614 drugs and 179 conditions by eHealthMe. Check the latest studies of Dermatitis atopic aggravated.

On Jul, 12, 2026

73,056 people reported to have side effects when taking Pregabalin.
Among them, 76 people (0.1%) have Dermatitis atopic aggravated.

Could Pregabalin cause Dermatitis atopic aggravated?

Among these 76 people:

What is the gender of people who have Dermatitis atopic aggravated when taking Pregabalin? *

female: 77.14 %
male: 22.86 %

What is the age of people who have Dermatitis atopic aggravated when taking Pregabalin? *

What are other drugs people take besides Pregabalin? *

Dupixent: 44 people, 57.89%
Lansoprazole: 23 people, 30.26%
Isosorbide Mononitrate: 19 people, 25.00%
Clozaril: 19 people, 25.00%
Mirabegron: 19 people, 25.00%
Memantine: 18 people, 23.68%
Ventolin: 17 people, 22.37%
Levothyroxine Sodium: 16 people, 21.05%
Gabapentin: 11 people, 14.47%
Senna: 10 people, 13.16%

What are other side effects people have besides Dermatitis atopic aggravated? *

Rashes (redness): 36 people, 47.37%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 23 people, 30.26%
Chest Pain: 23 people, 30.26%
Stable Angina (a constant chest pain): 19 people, 25.00%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 19 people, 25.00%
Delirium (wild excitement): 19 people, 25.00%
Pleural Effusion (water on the lungs): 19 people, 25.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 19 people, 25.00%
Iron Deficiency Anaemia: 19 people, 25.00%
Rickets (softening of bones): 19 people, 25.00%

What are the existing conditions these people have? *

Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 29 people, 38.16%
Asthma: 25 people, 32.89%
High Blood Pressure: 21 people, 27.63%
Diabetes: 19 people, 25.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 19 people, 25.00%
Dry Eyes (lack of adequate tears): 19 people, 25.00%
Stress And Anxiety: 19 people, 25.00%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 19 people, 25.00%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 19 people, 25.00%
Constipation: 19 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Pregabalin and have Dermatitis atopic aggravated?

- Check whether Dermatitis atopic aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pregabalin:

Pregabalin (74,069 reports)

Browse all side effects of Pregabalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatitis atopic aggravated:

Dermatitis atopic aggravated (614 drugs)

Browse all the conditions that are associated with Dermatitis atopic aggravated:

Dermatitis atopic aggravated (179 conditions)

Related publications that referenced our studies

de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Bonnet U, Taazimi B, Grabbe HD, "Pregabalin-Related Hypertriglyceridemia", Psychosomatics, 2014 Nov .
de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Bonnet U, Taazimi B, Grabbe HD, "Pregabalin-Related Hypertriglyceridemia", Psychosomatics, 2014 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on pregabalin (the active ingredients of Pregabalin) and Pregabalin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.